 SAN DIEGO, Jan. 8, 2021 PRNewswire -- Neurocrine Biosciences, Inc. Nasdaq: NBIX today provided an update on its business performance, including preliminary net product and inventory adjusted sales results of INGREZZA valbenazine for 2020, and key commercial and clinical development... 